Other soluble coagulation factors and associated plasma cofactors

Other soluble coagulation factors and associated plasma cofactors refers to a diverse group of proteins in the blood plasma that are essential for the coagulation cascade, excluding the primary targets like Thrombin or Factor Xa. This group includes zymogens of serine proteases such as Factor XI and Factor XII, non-enzymatic cofactors like Factor V and Factor VIII, and the multimeric adhesive protein von Willebrand Factor (vWF) (StatPearls, 2023). These proteins function in a coordinated sequence to amplify the initial stimulus of vascular injury, leading to the robust generation of fibrin and the formation of a stable blood clot (PubMed, PMID: 30149622). Deficiencies in these factors result in significant bleeding diatheses, most notably Hemophilia A (Factor VIII deficiency) and Hemophilia B (Factor IX deficiency), while their overactivity is linked to venous and arterial thrombosis (NIH, 2024). Therapeutic approaches targeting these factors include replacement therapies with plasma-derived or recombinant proteins, as well as novel agents like bispecific antibodies that mimic cofactor activity (e.g., emicizumab) or monoclonal antibodies that inhibit specific factors to prevent thrombosis (Nature Reviews Drug Discovery, 2022). Monitoring these factors is crucial in clinical practice, often utilizing assays like the activated partial thromboplastin time (aPTT) or specific factor activity levels to guide treatment and ensure patient safety.

Other names

Coagulation factorsClotting factorsPlasma cofactorsHemostatic factorsIntrinsic pathway factors

Replacement of deficient coagulation factors, mimetic activity of cofactors, and selective inhibition of protease activity within the intrinsic and common pathways of the coagulation cascade.